Literature DB >> 21098272

Sox10 directs neural stem cells toward the oligodendrocyte lineage by decreasing Suppressor of Fused expression.

Christine D Pozniak1, Abraham J Langseth, Gerrit J P Dijkgraaf, Youngshik Choe, Zena Werb, Samuel J Pleasure.   

Abstract

Oligodendrocyte precursor cells (OPCs) are lineage-restricted progenitors generally limited in vivo to producing oligodendrocytes. Mechanisms controlling genesis of OPCs are of interest because of their importance in myelin development and their potential for regenerative therapies in multiple sclerosis and dysmyelinating syndromes. We show here that the SoxE transcription factors (comprising Sox8, 9, and 10) induce multipotent neural precursor cells (NPCs) from the early postnatal subventricular zone (SVZ) to become OPCs in an autonomous manner. We performed a chromatin immunoprecipitation-based bioinformatic screen and identified Suppressor of Fused (Sufu) as a direct target of repression by Sox10. In vitro, overexpression of Sufu blocked OPC production, whereas RNAi-mediated inhibition augmented OPC production. Furthermore, mice heterozygous for Sufu have increased numbers of OPCs in the telencephalon during development. We conclude that Sox10 acts to restrict the potential of NPCs toward the oligodendrocyte lineage in part by regulating the expression of Sufu.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098272      PMCID: PMC3003047          DOI: 10.1073/pnas.1016485107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10.

Authors:  C Claus Stolt; Stephan Rehberg; Marius Ader; Petra Lommes; Dieter Riethmacher; Melitta Schachner; Udo Bartsch; Michael Wegner
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

2.  Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection.

Authors:  Q Richard Lu; Tao Sun; Zhimin Zhu; Nan Ma; Meritxell Garcia; Charles D Stiles; David H Rowitch
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

3.  The Sox9 transcription factor determines glial fate choice in the developing spinal cord.

Authors:  C Claus Stolt; Petra Lommes; Elisabeth Sock; Marie-Christine Chaboissier; Andreas Schedl; Michael Wegner
Journal:  Genes Dev       Date:  2003-07-01       Impact factor: 11.361

4.  Transcription factors Sox8 and Sox10 perform non-equivalent roles during oligodendrocyte development despite functional redundancy.

Authors:  C Claus Stolt; Petra Lommes; Ralf P Friedrich; Michael Wegner
Journal:  Development       Date:  2004-04-21       Impact factor: 6.868

5.  The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification.

Authors:  Qiao Zhou; David J Anderson
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

6.  Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice.

Authors:  Nathalie Picard-Riera; Laurence Decker; Cécile Delarasse; Karine Goude; Brahim Nait-Oumesmar; Roland Liblau; Danielle Pham-Dinh; Anne Baron-Van Evercooren
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

7.  The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages.

Authors:  Hirohide Takebayashi; Yoko Nabeshima; Shosei Yoshida; Osamu Chisaka; Kazuhiro Ikenaka; Yo-ichi Nabeshima
Journal:  Curr Biol       Date:  2002-07-09       Impact factor: 10.834

8.  Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling.

Authors:  Michael D Taylor; Xiaoyun Zhang; Ling Liu; Chi-Chung Hui; Todd G Mainprize; Stephen W Scherer; Brandon Wainwright; David Hogg; James T Rutka
Journal:  Oncogene       Date:  2004-06-03       Impact factor: 9.867

9.  Cooperation between sonic hedgehog and fibroblast growth factor/MAPK signalling pathways in neocortical precursors.

Authors:  Nicoletta Kessaris; Françoise Jamen; Lee L Rubin; William D Richardson
Journal:  Development       Date:  2004-02-11       Impact factor: 6.868

10.  Mutations in SUFU predispose to medulloblastoma.

Authors:  Michael D Taylor; Ling Liu; Corey Raffel; Chi-chung Hui; Todd G Mainprize; Xiaoyun Zhang; Ron Agatep; Sharon Chiappa; Luzhang Gao; Anja Lowrance; Aihau Hao; Alisa M Goldstein; Theodora Stavrou; Stephen W Scherer; Wieslaw T Dura; Brandon Wainwright; Jeremy A Squire; James T Rutka; David Hogg
Journal:  Nat Genet       Date:  2002-06-17       Impact factor: 38.330

View more
  43 in total

1.  Disrupted SOX10 function causes spongiform neurodegeneration in gray tremor mice.

Authors:  Sarah R Anderson; Inyoul Lee; Christine Ebeling; Dennis A Stephenson; Kelsey M Schweitzer; David Baxter; Tara M Moon; Sarah LaPierre; Benjamin Jaques; Derek Silvius; Michael Wegner; Leroy E Hood; George Carlson; Teresa M Gunn
Journal:  Mamm Genome       Date:  2014-11-16       Impact factor: 2.957

2.  Treatment with thyroxine restores myelination and clinical recovery after intraventricular hemorrhage.

Authors:  Linnea R Vose; Govindaiah Vinukonda; Sungro Jo; Omid Miry; Daniel Diamond; Ritesh Korumilli; Arslan Arshad; Muhammad T K Zia; Furong Hu; Robert J Kayton; Edmund F La Gamma; Rashmi Bansal; Antonio C Bianco; Praveen Ballabh
Journal:  J Neurosci       Date:  2013-10-30       Impact factor: 6.167

3.  Transcription factor induction of human oligodendrocyte progenitor fate and differentiation.

Authors:  Jing Wang; Suyog U Pol; Alexa K Haberman; Chunming Wang; Melanie A O'Bara; Fraser J Sim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

4.  Inhibition of CD147 improves oligodendrogenesis and promotes white matter integrity and functional recovery in mice after ischemic stroke.

Authors:  Shan Liu; Rong Jin; Adam Y Xiao; Wei Zhong; Guohong Li
Journal:  Brain Behav Immun       Date:  2019-07-26       Impact factor: 7.217

5.  Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors.

Authors:  Marc Ehrlich; Sabah Mozafari; Michael Glatza; Laura Starost; Sergiy Velychko; Anna-Lena Hallmann; Qiao-Ling Cui; Axel Schambach; Kee-Pyo Kim; Corinne Bachelin; Antoine Marteyn; Gunnar Hargus; Radia Marie Johnson; Jack Antel; Jared Sterneckert; Holm Zaehres; Hans R Schöler; Anne Baron-Van Evercooren; Tanja Kuhlmann
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-28       Impact factor: 11.205

Review 6.  Interplay between transcriptional control and chromatin regulation in the oligodendrocyte lineage.

Authors:  Marylens Hernandez; Patrizia Casaccia
Journal:  Glia       Date:  2015-05-12       Impact factor: 7.452

7.  PEDF is a novel oligodendrogenic morphogen acting on the adult SVZ and corpus callosum.

Authors:  Jiho Sohn; Vimal Selvaraj; Kouji Wakayama; Lori Orosco; Eunyoung Lee; Susan E Crawford; Fuzheng Guo; Jordan Lang; Makoto Horiuchi; Konstantinos Zarbalis; Takayuki Itoh; Wenbin Deng; David Pleasure
Journal:  J Neurosci       Date:  2012-08-29       Impact factor: 6.167

8.  Postnatal glucocorticoid-induced hypomyelination, gliosis, and neurologic deficits are dose-dependent, preparation-specific, and reversible.

Authors:  Muhammad T K Zia; Govindaiah Vinukonda; Linnea R Vose; Bala B R Bhimavarapu; Sanda Iacobas; Nishi K Pandey; Ann Marie Beall; Preeti Dohare; Edmund F LaGamma; Dumitru A Iacobas; Praveen Ballabh
Journal:  Exp Neurol       Date:  2014-09-28       Impact factor: 5.330

9.  Suppressor of Fused Is Critical for Maintenance of Neuronal Progenitor Identity during Corticogenesis.

Authors:  Odessa R Yabut; Gloria Fernandez; Trung Huynh; Keejung Yoon; Samuel J Pleasure
Journal:  Cell Rep       Date:  2015-09-17       Impact factor: 9.423

10.  SOX10 rs139883 polymorphism is associated with the age of onset in schizophrenia.

Authors:  Aihua Yuan; Weidong Li; Tao Yu; Chen Zhang; Dongxiang Wang; Dengtang Liu; Yifeng Xu; Huafang Li; Shunying Yu
Journal:  J Mol Neurosci       Date:  2013-03-02       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.